![](/img/cover-not-exists.png)
Post-nephrectomy adjuvant therapy for localized renal cell carcinoma (RCC): The phase III randomized, placebo-controlled CheckMate 914 study of nivolumab plus ipilimumab in patients at high risk of relapse
Bex, A., Russo, P., Tomita, Y., Grunwald, V., Ramirez, L.M., McHenry, M.B., Motzer, R.J.Volume:
18
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)31332-6
Date:
March, 2019
File:
PDF, 88 KB
english, 2019